section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
44/2002<br />
31 Oct/oct 2002 PCT Gazette - Section I - Gazette du PCT 21621<br />
(25) fr (26) fr<br />
(30) 01/05554 25 Apr/avr 2001 FR<br />
(25.04.2001)<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) MEDICINAL TABLET WITH PRO-<br />
LONGED RELEASE OF THE ACTIVE<br />
PRINCIPLE<br />
PASTILLE MEDICAMENTEUSE A LI-<br />
BERATION LENTE DU PRINCIPE AC-<br />
TIF<br />
(71) PIERRE FABRE MEDICAMENT<br />
[FR/FR]; 45, place Abel-Gance, F-92100<br />
Boulogne (FR).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) DUPINAY, Pierre [—/FR];LeVillage,<br />
F-31460 Toutens (FR). TORRES, Robert<br />
[—/FR]; 19, rue Docteur Arrazat, F-31520<br />
Ramonville Saint Agne (FR).<br />
(74) MARTIN, Jean-Jacques et al. / etc.; Cabinet<br />
Regimbeau, 20, rue de Chazelles, F-75847<br />
Paris Cedex 17 (FR).<br />
(81) BR CA CN JP MX US.<br />
(84) EP (AT BE CH CY DE DK ES FI FR GB GR<br />
IE IT LU MC NL PT SE TR).<br />
Published / Publiée : (c)<br />
(51) 7 A61K 9/22, 9/32, 9/36, 9/58, 9/62<br />
(11) WO 02/085335 (13) A1<br />
(21) PCT/US02/12140<br />
(22) 18 Apr/avr 2002 (18.04.2002)<br />
(25) en (26) en<br />
(30) 60/284,463 18 Apr/avr 2001 US<br />
(18.04.2001)<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) A NOVEL COATING FOR A SUS-<br />
TAINED RELEASE PHARMACEUTI-<br />
CAL COMPOSITION<br />
NOUVEL ENROBAGE DE COMPOSI-<br />
TION PHARMACEUTIQUE A LIBERA-<br />
TION LENTE<br />
(71) NOSTRUM PHARMACEUTICALS INC.<br />
[US/US]; 203 Somerset Court, Princeton, NJ<br />
08540 (US).<br />
(72) MULYE, Nirmal; 203 Somerset Court,<br />
Princeton, NJ 08540 (US).<br />
(74) GROLZ, Edward, W. et al. / etc.; Scully,<br />
Scott, Murphy & Presser, 400 Garden City<br />
Plaza, Garden City, NY 11530 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TN TR TT<br />
TZ UA UG UZ VN YU ZA ZM ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(51) 7 A61K 9/46<br />
(11) WO 02/085336 (13) A1<br />
(21) PCT/FR02/01321<br />
(22) 17 Apr/avr 2002 (17.04.2002)<br />
(25) fr (26) fr<br />
(30) 01/05389 20 Apr/avr 2001 FR<br />
(20.04.2001)<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) ORODISPERSIBLE EFFERVESCENT<br />
TABLETS<br />
COMPRIMES EFFERVESCENTS ORO-<br />
DISPERSIBLES<br />
(71) ETHYPHARM [FR/FR]; 21, rue Saint<br />
Matthieu, F-78550 Houdan (FR).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) DELMAS, Pascal [FR/CA]; 97 rue Mc-<br />
Culloch, Outremont, Quebec H2V 3L8 (CA).<br />
ZUCCARELLI, Jean-Marc [FR/FR]; 126<br />
chemin de la Parouquine, F-06600 Antibes<br />
(FR). MALLARD, Claire [FR/FR]; Rue des<br />
Petits Ponts, F-06250 Mougins le Haut (FR).<br />
MCGINITY, James, W. [US/US]; 4209<br />
Dunning Lane, Austin, TX 78746 (US).<br />
(74) TOUATI, Catherine et al. / etc.; Cabinet<br />
Plasseraud, 84, rue d’Amsterdam, F-75440<br />
Paris Cedex 09 (FR).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TN TR TT<br />
TZ UA UG US UZ VN YU ZA ZM ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
Declaration / Déclaration :<br />
(u) for / pour US only / seulement<br />
(51) 7 A61K 9/51<br />
(11) WO 02/085337 (13) A1<br />
(21) PCT/CA02/00542<br />
(22) 22 Apr/avr 2002 (22.04.2002)<br />
(25) en (26) en<br />
(30) 60/284,884 20 Apr/avr 2001 US<br />
(20.04.2001)<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) MICELLAR DRUG DELIVERY SYS-<br />
TEMS FOR HYDROPHOBIC DRUGS<br />
SYSTEMES D’ADMINISTRATION DE<br />
MEDICAMENT MICELLAIRE POUR<br />
MEDICAMENTS HYDROPHOBES<br />
(71) THE UNIVERSITY OF BRITISH CO-<br />
LUMBIA [CA/CA]; University-Industry<br />
Liaison Office, IRC Room 331, 2194 Health<br />
Sciences Mall, Vancouver, British Columbia<br />
V6T 1Z3 (CA).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) JACKSON, John, K. [CA/CA]; 540<br />
West 29th Avenue, Vancouver, British Columbia<br />
V5Z 2H7 (CA). ZASTRE, Jason<br />
[CA/CA]; 6950 Fremlin Street, Vancouver,<br />
British Columbia V6P 3W4 (CA). BURT,<br />
Helen, M. [CA/CA]; 3182West 28th Avenue,<br />
Vancouver, BritishColumbia V6L 1X5 (CA).<br />
(74) ROBINSON, J., Christopher et al. / etc.;<br />
Smart & Biggar, Suite 2200, 650 West Georgia<br />
Street, Box 11560 Vancouver Centre, Vancouver,<br />
British Columbia V6B 4N8 (CA).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TN TR TT<br />
TZ UA UG US UZ VN YU ZA ZM ZW.<br />
(84)AP(GHGMKELSMWMZSDSLSZTZ<br />
UG ZM ZW); EA (AM AZ BY KG KZ MD<br />
RUTJTM);EP(ATBECHCYDEDKES<br />
FI FR GB GR IE IT LU MC NL PT SE TR);<br />
OA(BFBJCFCGCICMGAGNGQGW<br />
ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(51) 7 A61K 9/72, 31/46<br />
(11) WO 02/085338 (13) A2<br />
(21) PCT/CA02/00450<br />
(22) 3 Apr/avr 2002 (03.04.2002)<br />
(25) en (26) en<br />
(30) 09/841,181 23 Apr/avr 2001<br />
(23.04.2001)<br />
US<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) IPRATROPIUM FORMULATION FOR<br />
PULMONARY INHALATION<br />
FORMULATION D’IPRATROPIUM<br />
POUR INHALATION PULMONAIRE<br />
(71) PHARMASCIENCE INC. [CA/CA]; 6111<br />
Royalmount Avenue, Suite 100, Montréal,<br />
Québec H4P 2T4 (CA).<br />
(72) WULFFHART,Harold;85SkymarkDrive,<br />
Classic, Suite 2006, North York, Toronto, Ontario<br />
M2H 3P2 (CA). AYOUB, Khaldoun;<br />
32 Tomlin Circle, Richmond Hill, Ontario<br />
L4C 7T3 (CA). LOGIUDICE, Rosemary;<br />
182 Misty Meadow Drive, Woodbridge, Ontario<br />
L4L 3V7 (CA). PISKORZ, Hanna;30<br />
Vitlor Drive, Richmond Hill, Ontario L4E<br />
3W3 (CA).<br />
(74) OGILVY RENAULT et al. / etc.; Suite<br />
1600, 1981 McGill College Avenue, Montreal,<br />
Québec H3A 2Y3 (CA).<br />
(81) AU CA JP.<br />
(84)EP(ATBECHCYDEDKESFIFRGBGR<br />
IE IT LU MC NL PT SE TR).<br />
(51) 7 A61K 9/72<br />
(11) WO 02/085339 (13) A1<br />
(21) PCT/US02/07550<br />
(22) 13 Mar/mar 2002 (13.03.2002)<br />
(25) en (26) en<br />
(30) 09/834,158 12 Apr/avr 2001<br />
(12.04.2001)<br />
US<br />
(43) 31 Oct/oct 2002 (31.10.2002)<br />
(54) PHASE CHANGE THERMAL INTER-<br />
FACE COMPOSITION HAVING IN-<br />
DUCED BONDING PROPERTY<br />
COMPOSITION D’INTERFACE THER-<br />
MIQUE A CHANGEMENT DE PHASE<br />
PRESENTANT UNE PROPRIETE DE<br />
LIAISON INDUITE